Inactivation ofCronobacterspp. (Enterobacter sakazakii) in infant formula using lactic acid, copper sulfate and monolaurin

Inactivation of Cronobacter spp. (Enterobacter sakazakii) in infant formula using lactic acid, copper sulfate and monolaurin.

AIMS To investigate the effect of lactic acid (LA), copper (II), and monolaurin as natural antimicrobials against Cronobacter in infant formula. METHODS AND RESULTS The effect of LA (0.1, 0.2 and 0.3% v/v), copper (II) (10, 50 and 100 microg ml(-1)) and monolaurin (1000, 2000, and 3000 microg ml(-1)) suspended into tween-80 or dissolved in ethanol against Cronobacter in infant formula was inv...

Thermal Resistance, Survival and Inactivation of Enterobacter Sakazakii (cronobacter Spp.) in Powdered and Reconstituted Infant Formula

Enterobacter sakazakii has recently been recognized as an opportunistic foodborne pathogen, and dry infant formula serves as the mode of transmission. The objectives of this study were to investigate the heat resistance, survival and inactivation under room and refrigeration temperatures storage of dry and reconstituted infant formula milk (IFM). E. sakazakii strains (eight strains) showed a wi...

Enterobacter sakazakii: an emerging pathogen in powdered infant formula.

Enterobacter sakazakii represents a significant risk to the health of neonates. This bacterium is an emerging opportunistic pathogen that is associated with rare but life-threatening cases of meningitis, necrotizing enterocolitis, and sepsis in premature and full-term infants. Infants aged <28 days are considered to be most at risk. Feeding with powdered infant formula (PIF) has been epidemiolo...

Powdered infant formula and fatal infection with Enterobacter sakazakii.

Powder infant formula milk contaminated with Enterobacter sakazakii.

To clarify the route and source of Enterobacter sakazakii infection in a basic study, we analyzed powder infant formula milk (PIF), which may be an important source of infantile infection, regarding contamination with Enterobacteriaceae including this type of bacteria, and conducted drug sensitivity tests with various antimicrobial agents. Enterobacteriaceae was isolated 36 (24.2%) of 149 PIF s...